donitriptan
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
HTR1B agonist
HTR1D agonist
- G protein-coupled receptor 44ANTAGONIST
PTGDR2 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1- Mol. weight
- 403.49 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1742428 ↗
Also known as
- 4-(4-(2-(2-aminoethyl-1h-indol-5-yloxyl)acetyl)piperazinyl-1-yl)benzonitrile
- donitriptan
- donitriptan
- donitriptan
- f11356
- f 11356
- f-11356
- f-11356
- f12640
- f 12640
- f-12640